News coverage about Vascular Solutions (NASDAQ:VASC) has trended somewhat positive recently, according to Accern. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Vascular Solutions earned a daily sentiment score of 0.15 on Accern’s scale. Accern also gave media headlines about the medical device company an impact score of 45.3811342798317 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
These are some of the media headlines that may have effected Accern Sentiment’s scoring:
- Teleflex (TFX) Q2 2017 Results – Earnings Call Transcript (seekingalpha.com)
- Vascular Solutions (VASC) versus Cepheid (CPHD) Head-To-Head Contrast (americanbankingnews.com)
- 6 Things You Need To Know About New FBI Director Christopher Wray (dailywire.com)
- Self-Expanding Peripheral Vascular Stents Market to Partake Significant Development By 2024 (mynewsdesk.com)
- Self-Expanding Peripheral Vascular Stents Market to Register Steady Growth During 2016 – 2024 (medgadget.com)
Vascular Solutions (NASDAQ VASC) remained flat at $56.00 during midday trading on Tuesday. The firm’s 50-day moving average is $55.89 and its 200 day moving average is $51.22. Vascular Solutions has a one year low of $25.06 and a one year high of $57.15.
TRADEMARK VIOLATION WARNING: This report was posted by BBNS and is the property of of BBNS. If you are reading this report on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The original version of this report can be viewed at https://baseballnewssource.com/markets/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-vascular-solutions-nasdaqvasc-share-price-updated/1312173.html.
About Vascular Solutions
Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.
Receive News & Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related companies with our FREE daily email newsletter.